Vincent CORVEST, Senior Scientist & Business Manager at CALIXAR, will be pleased to present the poster “Toolbox For Native Membrane Targets” during the Protein & Antibody Engineering Summit in Barcelona, from November 14 to 16, 2022. You will discover the CALIXAR fully native process to customize membrane proteins, look at our developing pipeline, and discuss your challenging targets to identify potential collaboration.CALIXAR is a biotech company specialized in the identification and isolation of functional membrane therapeutic targets and antigens (GPCRs, Ion channels, Transporters, …). The company is currently investing in the extension of its pipeline of highly druggable membrane protein targets and native antigens. Within the next few years, CALIXAR will be able to offer to Pharma companies native and functional therapeutic targets validated and in a ready-to-discovery format.The company wants to become a leader in the early discovery segment of drug development based on complex therapeutic targets (membrane proteins), a market predicted to be worth €70 bn by 2025Meet Vincent during these 3 days of event to learn more on CALIXAR’s proprietary technology and exchange with him about your targets to secure the generation of new drugs, antibodies, or small molecules.About PEGS EUROPE:Network with 1,200 colleagues at PEGS Europe, the largest protein & antibody engineering event in Europe, which has been described as "the best biologics technology meeting in Europe." Last year, nearly 900 delegates from 35 countries, including 78% from pharma and biotech organizations, convened in beautiful Barcelona and online to discuss the latest advances in protein and antibody engineering.For more information and meet us: PEGS - EUROPE
